DRY PRESERVATION OF TRANSPLANTABLE VEINS

Information

  • Research Project
  • 3502029
  • ApplicationId
    3502029
  • Core Project Number
    R43HL046606
  • Full Project Number
    1R43HL046606-01
  • Serial Number
    46606
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/1/1991 - 33 years ago
  • Project End Date
    10/30/1991 - 33 years ago
  • Program Officer Name
  • Budget Start Date
    5/1/1991 - 33 years ago
  • Budget End Date
    10/30/1991 - 33 years ago
  • Fiscal Year
    1991
  • Support Year
    1
  • Suffix
  • Award Notice Date
    4/19/1991 - 33 years ago
Organizations

DRY PRESERVATION OF TRANSPLANTABLE VEINS

The long-term objective of this research proposal is to develop technology and devices for the cryopreservation and drying of human allograft saphenous veins and ultimately bioprosthetic heterograft vessels which allow storage in a non-frozen state (4o - 22oC). Veins will be preserved by vitrification with incorporation of naturally occurring dry protectant sugars and dried by molecular distillation in a manner quantitatively related to the water phases present. Evaluation will be made by light and electron microscopy, strength/elasticity and flow measurements, biochemical assays, and immunological tests for Class I and II major histocompatibility antigens. The potential advantages of such veins would be longer and more convenient storage pregraft, and significantly reduced structural damage during processing which, it is anticipated, would result in reduced thromboembolic risk post graft and longer graft life spans. In addition, advantage will be taken of the ability of the processing method to maintain transient partial endothelial cell function, but not viability. This should allow endothelial cells to cover the intima for a limited period thereby avoiding immediate thrombo-occlusion, but these compromised cells would ultimately be replaced by autologous endothelial cells. Later, Phase II studies will focus on animal implant models, the feasibility of scale- up, and design of a prototype commercial processing machine.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    LIFECELL CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    SOMERVILLE
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    08876
  • Organization District
    UNITED STATES